TreeWAS – Variant ID: rs4853036

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z11.0 Special screening examination for intestinal infectious diseases	0.213	0.787	0.000
Z11 Special screening examination for infectious and parasitic diseases	0.122	0.878	0.000
Z11.2 Special screening examination for other bacterial diseases	0.111	0.889	0.000
Z11.8 Special screening examination for other infectious and parasitic diseases	0.098	0.902	0.000
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified	0.096	0.904	0.000
Z11.1 Special screening examination for respiratory tuberculosis	0.093	0.907	0.000
Z11.6 Special screening examination for other protozoal diseases and helminthiases	0.088	0.912	0.000
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission	0.088	0.912	0.000
Z11.4 Special screening examination for human immunodeficiency virus [HIV]	0.060	0.940	0.000
Z11.5 Special screening examination for other viral diseases	0.059	0.941	0.000
G63.2 Diabetic polyneuropathy	0.051	0.949	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.044	0.956	0.000
K14.0 Glossitis	0.043	0.957	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.042	0.958	0.000
C82.0 Small cleaved cell, follicular	0.042	0.958	0.000
K14.8 Other diseases of tongue	0.042	0.958	0.000
K14 Diseases of tongue	0.041	0.959	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.040	0.960	0.000
C82.3 Follicular lymphoma grade IIIa	0.038	0.962	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.035	0.965	0.000
K14.6 Glossodynia	0.034	0.966	0.000
K14.9 Disease of tongue, unspecified	0.033	0.967	0.000
Z87.4 Personal history of diseases of the genito-urinary system	0.033	0.967	0.000
C82.4 Follicular lymphoma grade IIIb	0.033	0.967	0.000
C82.6 Cutaneous follicle centre lymphoma	0.032	0.968	0.000
C82.5 Diffuse follicle centre lymphoma	0.032	0.968	0.000
K14.1 Geographic tongue	0.031	0.969	0.000
K14.5 Plicated tongue	0.030	0.970	0.000
K14.4 Atrophy of tongue papillae	0.030	0.970	0.000
K14.3 Hypertrophy of tongue papillae	0.030	0.970	0.000
K14.2 Median rhomboid glossitis	0.030	0.970	0.000
C82.2 Large cell, follicular	0.028	0.972	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.026	0.974	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.023	0.977	0.000
G63 Polyneuropathy in diseases classified elsewhere	0.023	0.977	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.023	0.977	0.000
C88 Malignant immunoproliferative diseases	0.023	0.977	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.022	0.978	0.000
C86 Other specified types of T/NK-cell lymphoma	0.021	0.979	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.021	0.979	0.000
C83.0 Small cell (diffuse)	0.021	0.979	0.000
C93 Monocytic leukaemia	0.020	0.980	0.000
C95 Leukaemia of unspecified cell type	0.020	0.980	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.020	0.980	0.000
C84.0 Mycosis fungoides	0.019	0.980	0.000
C84.4 Peripheral T-cell lymphoma	0.019	0.981	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.019	0.981	0.000
C94 Other leukaemias of specified cell type	0.019	0.981	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.019	0.981	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.018	0.982	0.000
C84.5 Other and unspecified T-cell lymphomas	0.018	0.982	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.017	0.982	0.000
C83.1 Small cleaved cell (diffuse)	0.017	0.983	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.017	0.983	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.017	0.983	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.017	0.983	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.017	0.983	0.000
C84.3 Lymphoepithelioid lymphoma	0.017	0.983	0.000
C84.2 T-zone lymphoma	0.017	0.983	0.000
C84.1 Sezary's diease	0.017	0.983	0.000
G63.8 Polyneuropathy in other diseases classified elsewhere	0.017	0.983	0.000
G63.6 Polyneuropathy in other musculoskeletal disorders	0.017	0.983	0.000
G63.5 Polyneuropathy in systemic connective tissue disorders	0.017	0.983	0.000
G63.4 Polyneuropathy in nutritional deficiency	0.017	0.983	0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.017	0.983	0.000
G63.1 Polyneuropathy in neoplastic disease	0.017	0.983	0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.017	0.983	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.017	0.983	0.000
C85.0 Lymphosarcoma	0.017	0.983	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.016	0.984	0.000
C88.7 Other malignant immunoproliferative diseases	0.016	0.984	0.000
C88.3 Immunoproliferative small intestinal disease	0.016	0.984	0.000
C88.2 Gamma heavy chain disease	0.016	0.984	0.000
C88.1 Alpha heavy chain disease	0.016	0.984	0.000
C92 Myeloid leukaemia	0.016	0.984	0.000
C93.1 Chronic monocytic leukaemia	0.016	0.984	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.016	0.984	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.015	0.984	0.000
C86.4 Blastic NK-cell lymphoma	0.015	0.984	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.015	0.984	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.015	0.984	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.015	0.984	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.015	0.984	0.000
C83.6 Undifferentiated (diffuse)	0.015	0.984	0.000
C83.5 Lymphoblastic (diffuse)	0.015	0.984	0.000
C83.4 Immunoblastic (diffuse)	0.015	0.984	0.000
C83.2 Mixed small and large cell (diffuse)	0.015	0.984	0.000
C95.0 Acute leukaemia of unspecified cell type	0.015	0.985	0.000
C95.9 Leukaemia, unspecified	0.015	0.985	0.000
C93.9 Monocytic leukaemia, unspecified	0.014	0.985	0.000
C93.7 Other monocytic leukaemia	0.014	0.985	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.014	0.985	0.000
C93.2 Subacute monocytic leukaemia	0.014	0.985	0.000
C93.0 Acute monocytic leukaemia	0.014	0.985	0.000
C95.7 Other leukaemia of unspecified cell type	0.014	0.985	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.014	0.985	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.014	0.985	0.000
C85.1 B-cell lymphoma, unspecified	0.014	0.986	0.000
C94.7 Other specified leukaemias	0.014	0.986	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.014	0.986	0.000
C94.5 Acute myelofibrosis	0.014	0.986	0.000
C94.4 Acute panmyelosis	0.014	0.986	0.000
C94.3 Mast cell leukaemia	0.014	0.986	0.000
C94.2 Acute megakaryoblastic leukaemia	0.014	0.986	0.000
C94.1 Chronic erythraemia	0.014	0.986	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.014	0.986	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.014	0.986	0.000
C96.8 Histiocytic sarcoma	0.014	0.986	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.014	0.986	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.014	0.986	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.014	0.986	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.014	0.986	0.000
C96.3 True histiocytic lymphoma	0.014	0.986	0.000
C96.2 Malignant mast cell tumour	0.014	0.986	0.000
C96.1 Malignant histiocytosis	0.014	0.986	0.000
C96.0 Letterer-Siwe disease	0.014	0.986	0.000
C83.7 Burkitt's tumour	0.014	0.986	0.000
C92.0 Acute myeloid leukaemia	0.013	0.987	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.000	0.988	0.012
C92.7 Other myeloid leukaemia	0.012	0.988	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.012	0.988	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.012	0.988	0.000
C92.5 Acute myelomonocytic leukaemia	0.012	0.988	0.000
C92.3 Myeloid sarcoma	0.012	0.988	0.000
C92.2 Subacute myeloid leukaemia	0.012	0.988	0.000
C81 Hodgkin's disease	0.011	0.989	0.000
N30.3 Trigonitis	0.011	0.989	0.000
C92.9 Myeloid leukaemia, unspecified	0.011	0.989	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.011	0.989	0.000
Z48.0 Attention to surgical dressings and sutures	0.011	0.989	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.010	0.989	0.000
C92.4 Acute promyelocytic leukaemia	0.010	0.990	0.000
C92.1 Chronic myeloid leukaemia	0.010	0.990	0.000
C81.2 Mixed cellularity	0.009	0.991	0.000
E10.4 With neurological complications	0.009	0.991	0.000
S70 Superficial injury of hip and thigh	0.009	0.991	0.000
N20.0 Calculus of kidney	0.009	0.991	0.000
C81.7 Other Hodgkin's disease	0.008	0.991	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.008	0.991	0.000
C81.3 Lymphocytic depletion	0.008	0.991	0.000
N20.1 Calculus of ureter	0.008	0.992	0.000
S70.1 Contusion of thigh	0.008	0.992	0.000
N20 Calculus of kidney and ureter	0.008	0.992	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.008	0.992	0.000
S70.8 Other superficial injuries of hip and thigh	0.008	0.992	0.000
E10.5 With peripheral circulatory complications	0.008	0.992	0.000
N20.9 Urinary calculus, unspecified	0.008	0.992	0.000
N39.3 Stress incontinence	0.008	0.992	0.000
C81.0 Lymphocytic predominance	0.008	0.992	0.000
C91 Lymphoid leukaemia	0.008	0.992	0.000
R56.8 Other and unspecified convulsions	0.000	0.992	0.008
E10 Insulin-dependent diabetes mellitus	0.007	0.993	0.000
Z86.5 Personal history of other mental and behavioural disorders	0.000	0.993	0.007
E10.3 With ophthalmic complications	0.007	0.993	0.000
S70.7 Multiple superficial injuries of hip and thigh	0.007	0.993	0.000
M47.92 Spondylosis, unspecified (Cervical region)	0.000	0.994	0.006
M19.01 Primary arthrosis of other joints (Shoulder region)	0.000	0.994	0.006
E10.6 With other specified complications	0.006	0.994	0.000
E10.8 With unspecified complications	0.006	0.994	0.000
C90.1 Plasma cell leukaemia	0.006	0.994	0.000
G40 Epilepsy	0.000	0.994	0.006
C81.1 Nodular sclerosis	0.006	0.994	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.006	0.994	0.000
C91.7 Other lymphoid leukaemia	0.006	0.994	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.006	0.994	0.000
C91.5 Adult T-cell leukaemia	0.006	0.994	0.000
C91.3 Prolymphocytic leukaemia	0.006	0.994	0.000
C91.2 Subacute lymphocytic leukaemia	0.006	0.994	0.000
N20.2 Calculus of kidney with calculus of ureter	0.006	0.994	0.000
C81.9 Hodgkin's disease, unspecified	0.006	0.994	0.000
E10.2 With renal complications	0.006	0.994	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.000	0.994	0.006
C91.0 Acute lymphoblastic leukaemia	0.006	0.994	0.000
E10.7 With multiple complications	0.006	0.994	0.000
C90.3 Solitary plasmacytoma	0.005	0.994	0.000
Q51.3 Bicornate uterus	0.005	0.995	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.000	0.995	0.005
C91.4 Hairy-cell leukaemia	0.005	0.995	0.000
I07.1 Tricuspid insufficiency	0.000	0.995	0.005
E10.1 With ketoacidosis	0.005	0.995	0.000
R52.1 Chronic intractable pain	0.005	0.995	0.000
S70.0 Contusion of hip	0.005	0.995	0.000
C91.9 Lymphoid leukaemia, unspecified	0.004	0.995	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.000	0.995	0.005
O34.2 Maternal care due to uterine scar from previous surgery	0.005	0.995	0.000
H04.9 Disorder of lachrymal system, unspecified	0.000	0.995	0.005
T88.4 Failed or difficult intubation	0.005	0.995	0.000
Q51 Congenital malformations of uterus and cervix	0.005	0.995	0.000
C90.2 Plasmacytoma, extramedullary	0.004	0.995	0.000
E21.3 Hyperparathyroidism, unspecified	0.005	0.995	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
H04 Disorders of lachrymal system	0.000	0.995	0.005
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.000	0.995	0.004
G40.4 Other generalised epilepsy and epileptic syndromes	0.000	0.995	0.004
H04.8 Other disorders of lachrymal system	0.000	0.995	0.004
E10.0 With coma	0.004	0.996	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.000	0.996	0.004
C83.3 Large cell (diffuse)	0.004	0.996	0.000
Q51.2 Other doubling of uterus	0.004	0.996	0.000
G40.5 Special epileptic syndromes	0.000	0.996	0.004
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.000	0.996	0.004
E27.1 Primary adrenocortical insufficiency	0.000	0.996	0.004
O34.8 Maternal care for other abnormalities of pelvic organs	0.004	0.996	0.000
H04.1 Other disorders of lachrymal gland	0.000	0.996	0.004
H04.2 Epiphora	0.000	0.996	0.004
T88.9 Complication of surgical and medical care, unspecified	0.004	0.996	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.004	0.996	0.000
T88 Other complications of surgical and medical care, not elsewhere classified	0.004	0.996	0.000
S62.61 Fracture of other finger (open)	0.000	0.996	0.004
N81.3 Complete uterovaginal prolapse	0.004	0.996	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.000	0.996	0.004
Q51.9 Congenital malformation of uterus and cervix, unspecified	0.003	0.996	0.000
Q51.7 Congenital fistulae between uterus and digestive and urinary tracts	0.003	0.996	0.000
Q51.6 Embryonic cyst of cervix	0.003	0.996	0.000
Q51.5 Agenesis and aplasia of cervix	0.003	0.996	0.000
Q51.4 Unicornate uterus	0.003	0.996	0.000
Q51.1 Doubling of uterus with doubling of cervix and vagina	0.003	0.996	0.000
Q51.0 Agenesis and aplasia of uterus	0.003	0.996	0.000
Q51.8 Other congenital malformations of uterus and cervix	0.003	0.996	0.000
T88.6 Anaphylactic shock due to adverse effect of correct drug or medicament properly administered	0.004	0.996	0.000
N62 Hypertrophy of breast	0.004	0.996	0.000
H04.0 Dacryoadenitis	0.000	0.996	0.003
G40.8 Other epilepsy	0.000	0.997	0.003
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.000	0.997	0.003
H04.6 Other changes in lachrymal passages	0.000	0.997	0.003
Q50-Q56 Congenital malformations of genital organs	0.003	0.997	0.000
Q54.0 Hypospadias, balanic	0.003	0.997	0.000
H04.4 Chronic inflammation of lachrymal passages	0.000	0.997	0.003
O34.7 Maternal care for abnormality of vulva and perineum	0.003	0.997	0.000
Q54 Hypospadias	0.003	0.997	0.000
O34.3 Maternal care for cervical incompetence	0.003	0.997	0.000
R56 Convulsions, not elsewhere classified	0.000	0.997	0.003
O34.1 Maternal care for tumour of corpus uteri	0.003	0.997	0.000
T88.8 Other specified complications of surgical and medical care, not elsewhere classified	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
H43.8 Other disorders of vitreous body	0.000	0.997	0.003
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.003	0.997	0.000
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.003	0.997	0.000
O34.6 Maternal care for abnormality of vagina	0.003	0.997	0.000
O34.5 Maternal care for other abnormalities of gravid uterus	0.003	0.997	0.000
E85.4 Organ-limited amyloidosis	0.000	0.997	0.003
T88.2 Shock due to anaesthesia	0.003	0.997	0.000
T88.3 Malignant hyperthermia due to anaesthesis	0.003	0.997	0.000
T88.1 Other complications following immunisation, not elsewhere classified	0.003	0.997	0.000
T88.0 Infection following immunisation	0.003	0.997	0.000
Q55 Other congenital malformations of male genital organs	0.003	0.997	0.000
R63.4 Abnormal weight loss	0.003	0.997	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.003	0.997	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.997	0.003
R52.0 Acute pain	0.000	0.997	0.003
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Q52 Other congenital malformations of female genitalia	0.003	0.997	0.000
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)	0.003	0.997	0.000
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.997	0.003
Q56 Indeterminate sex and pseudohermaphroditism	0.003	0.997	0.000
E55.9 Vitamin D deficiency, unspecified	0.003	0.997	0.000
L43.9 Lichen planus, unspecified	0.003	0.997	0.000
M19.0 Primary arthrosis of other joints	0.000	0.997	0.003
T88.7 Unspecified adverse effect of drug or medicament	0.003	0.997	0.000
Q53 Undescended testicle	0.003	0.997	0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.997	0.003
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
O34.4 Maternal care for other abnormalities of cervix	0.002	0.997	0.000
Q54.8 Other hypospadias	0.002	0.997	0.000
Q54.4 Congenital chordee	0.002	0.997	0.000
Q54.3 Hypospadias, perineal	0.002	0.997	0.000
Q54.2 Hypospadias, penoscrotal	0.002	0.997	0.000
R56.0 Febrile convulsions	0.000	0.997	0.002
Z82.3 Family history of stroke	0.000	0.997	0.003
O34.0 Maternal care for congenital malformation of uterus	0.002	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
G40.9 Epilepsy, unspecified	0.000	0.997	0.003
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.997	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.000	0.997	0.003
H02.0 Entropion and trichiasis of eyelid	0.003	0.997	0.000
Q55.4 Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate	0.002	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Q54.1 Hypospadias, penile	0.002	0.997	0.000
G64 Other disorders of peripheral nervous system	0.002	0.997	0.000
E85.9 Amyloidosis, unspecified	0.000	0.997	0.002
Q54.9 Hypospadias, unspecified	0.002	0.997	0.000
G60 Hereditary and idiopathic neuropathy	0.002	0.997	0.000
Q50.0 Congenital absence of ovary	0.002	0.997	0.000
E10.9 Without complications	0.002	0.998	0.000
H43.1 Vitreous haemorrhage	0.000	0.998	0.002
Q55.6 Other congenital malformations of penis	0.002	0.998	0.000
M19.00 Primary arthrosis of other joints (Multiple sites)	0.000	0.998	0.002
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.998	0.002
N80.3 Endometriosis of pelvic peritoneum	0.002	0.998	0.000
T88.5 Other complications of anaesthesia	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
M19.06 Primary arthrosis of other joints-Lower leg	0.000	0.998	0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.002	0.998	0.000
Q52.1 Doubling of vagina	0.002	0.998	0.000
Q55.9 Congenital malformation of male genital organ, unspecified	0.002	0.998	0.000
Q55.8 Other specified congenital malformations of male genital organs	0.002	0.998	0.000
Q55.5 Congenital absence and aplasia of penis	0.002	0.998	0.000
Q55.3 Atresia of vas deferens	0.002	0.998	0.000
Q55.1 Hypoplasia of testis and scrotum	0.002	0.998	0.000
Q55.0 Absence and aplasia of testis	0.002	0.998	0.000
I07 Rheumatic tricuspid valve diseases	0.000	0.998	0.002
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.002	0.998	0.000
Q50.3 Other congenital malformations of ovary	0.002	0.998	0.000
Q50.2 Congenital torsion of ovary	0.002	0.998	0.000
Q50.1 Developmental ovarian cyst	0.002	0.998	0.000
K60.0 Acute anal fissure	0.002	0.998	0.000
Q52.9 Congenital malformation of female genitalia, unspecified	0.002	0.998	0.000
Q52.8 Other specified congenital malformations of female genitalia	0.002	0.998	0.000
Q52.7 Other congenital malformations of vulva	0.002	0.998	0.000
Q52.6 Congenital malformation of clitoris	0.002	0.998	0.000
Q52.4 Other congenital malformations of vagina	0.002	0.998	0.000
Q52.3 Imperforate hymen	0.002	0.998	0.000
Q52.2 Congenital rectovaginal fistula	0.002	0.998	0.000
Q52.0 Congenital absence of vagina	0.002	0.998	0.000
G60.8 Other hereditary and idiopathic neuropathies	0.002	0.998	0.000
I69 Sequelae of cerebrovascular disease	0.000	0.998	0.002
E21.2 Other hyperparathyroidism	0.002	0.998	0.000
Q50.5 Embryonic cyst of broad ligament	0.002	0.998	0.000
Q56.4 Indeterminate sex, unspecified	0.002	0.998	0.000
Q56.3 Pseudohermaphroditism, unspecified	0.002	0.998	0.000
Q56.2 Female pseudohermaphroditism, not elsewhere classified	0.002	0.998	0.000
Q56.1 Male pseudohermaphroditism, not elsewhere classified	0.002	0.998	0.000
Q56.0 Hermaphroditism, not elsewhere classified	0.002	0.998	0.000
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)	0.000	0.998	0.002
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.000	0.998	0.002
Q53.9 Undescended testicle, unspecified	0.002	0.998	0.000
Q53.2 Undescended testicle, bilateral	0.002	0.998	0.000
Q53.0 Ectopic testis	0.002	0.998	0.000
Q52.5 Fusion of labia	0.002	0.998	0.000
Q55.2 Other congenital malformations of testis and scrotum	0.002	0.998	0.000
H43 Disorders of vitreous body	0.000	0.998	0.002
D80.1 Nonfamilial hypogammaglobulinaemia	0.002	0.998	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.002	0.998	0.000
Q53.1 Undescended testicle, unilateral	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
E85 Amyloidosis	0.000	0.998	0.002
M19.03 Primary arthrosis of other joints (Forearm)	0.000	0.998	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
G60.3 Idiopathic progressive neuropathy	0.002	0.998	0.000
G60.2 Neuropathy in association with hereditary ataxia	0.002	0.998	0.000
G60.1 Refsum's disease	0.002	0.998	0.000
E21.4 Other specified disorders of parathyroid gland	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.002	0.998	0.000
G60.9 Hereditary and idiopathic neuropathy, unspecified	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.998	0.002
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.000	0.998	0.002
B18.2 Chronic viral hepatitis C	0.002	0.998	0.000
E83.1 Disorders of iron metabolism	0.002	0.998	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.000	0.998	0.002
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
N60.2 Fibroadenosis of breast	0.000	0.998	0.002
M19.08 Primary arthrosis of other joints (Other)	0.000	0.998	0.002
I07.9 Tricuspid valve disease, unspecified	0.000	0.998	0.002
I07.8 Other tricuspid valve diseases	0.000	0.998	0.002
I07.2 Tricuspid stenosis with insufficiency	0.000	0.998	0.002
I07.0 Tricuspid stenosis	0.000	0.998	0.002
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.000	0.998	0.002
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.998	0.002
M19.09 Primary arthrosis of other joints (Site unspecified)	0.000	0.998	0.002
M60.99 Myositis, unspecified (Site unspecified)	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
M19.04 Primary arthrosis of other joints (Hand)	0.000	0.998	0.002
B17.1 Acute hepatitis C	0.002	0.998	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.002	0.998	0.000
G60.0 Hereditary motor and sensory neuropathy	0.002	0.998	0.000
A63.0 Anogenital (venereal) warts	0.002	0.998	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.000	0.998	0.002
R82 Other abnormal findings in urine	0.002	0.998	0.000
Q82.8 Other specified congenital malformations of skin	0.000	0.998	0.002
R82.8 Abnormal findings on cytological and histological examination of urine	0.002	0.998	0.000
F29 Unspecified nonorganic psychosis	0.002	0.998	0.000
H43.0 Vitreous prolapse	0.000	0.998	0.002
H81.1 Benign paroxysmal vertigo	0.002	0.998	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.998	0.002
I60 Subarachnoid haemorrhage	0.000	0.998	0.002
N30 Cystitis	0.002	0.998	0.000
H61.2 Impacted cerumen	0.000	0.998	0.002
E85.8 Other amyloidosis	0.000	0.998	0.002
E85.2 Heredofamilial amyloidosis, unspecified	0.000	0.998	0.002
E85.1 Neuropathic heredofamilial amyloidosis	0.000	0.998	0.002
E85.0 Nonneuropathic heredofamilial amyloidosis	0.000	0.998	0.002
N30.0 Acute cystitis	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
M53.3 Sacrococcygeal disorders, not elsewhere classified	0.000	0.998	0.002
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
E21.0 Primary hyperparathyroidism	0.002	0.998	0.000
H43.3 Other vitreous opacities	0.000	0.998	0.002
M67.8 Other specified disorders of synovium and tendon	0.002	0.998	0.000
N30.2 Other chronic cystitis	0.002	0.998	0.000
W19.9 Unspecified place	0.000	0.998	0.002
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.002	0.998	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.002	0.998	0.000
E85.3 Secondary systemic amyloidosis	0.000	0.998	0.002
D80 Immunodeficiency with predominantly antibody defects	0.002	0.998	0.000
H43.2 Crystalline deposits in vitreous body	0.000	0.998	0.002
R82.9 Other and unspecified abnormal finding in urine	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
Z91.6 Personal history of other physical trauma	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
I62 Other nontraumatic intracranial haemorrhage	0.000	0.998	0.002
M19.02 Primary arthrosis of other joints (Upper arm)	0.000	0.998	0.001
H43.9 Disorder of vitreous body, unspecified	0.000	0.998	0.002
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.000	0.998	0.002
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.000	0.998	0.002
M47.9 Spondylosis, unspecified	0.000	0.998	0.002
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.000	0.998	0.002
K02.8 Other dental caries	0.000	0.998	0.002
R82.4 Acetonuria	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
M62.88 Other specified disorders of muscle (Other)	0.000	0.998	0.002
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.002	0.998	0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.000	0.998	0.002
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.001	0.998	0.000
R82.3 Haemoglobinuria	0.001	0.998	0.000
R82.2 Biliuria	0.001	0.998	0.000
R82.0 Chyluria	0.001	0.998	0.000
H90 Conductive and sensorineural hearing loss	0.000	0.998	0.002
I60-I69 Cerebrovascular diseases	0.000	0.998	0.002
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.001	0.998	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.000	0.998	0.001
J38.3 Other diseases of vocal cords	0.000	0.998	0.002
N39.4 Other specified urinary incontinence	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
M94.88 Other specified disorders of cartilage (Other)	0.000	0.998	0.002
G41.9 Status epilepticus, unspecified	0.000	0.998	0.002
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.000	0.998	0.002
R82.1 Myoglobinuria	0.001	0.998	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.001	0.998	0.000
M80.1 Postoophorectomy osteoporosis with pathological fracture	0.001	0.998	0.000
M47.94 Spondylosis, unspecified (Thoracic region)	0.000	0.998	0.001
M53.37 Sacrococcygeal disorders, not elsewhere classified-Lumbosac	0.000	0.998	0.001
M53.36 Sacrococcygeal disorders, not elsewhere classified-Lumbar	0.000	0.998	0.001
M53.35 Sacrococcygeal disorders, not elsewhere classified-Thoracol	0.000	0.998	0.001
M53.34 Sacrococcygeal disorders, not elsewhere classified-Thoracic	0.000	0.998	0.001
M53.33 Sacrococcygeal disorders, not elsewhere classified-Cervicot	0.000	0.998	0.001
M53.32 Sacrococcygeal disorders, not elsewhere classified-Cervical	0.000	0.998	0.001
M53.31 Sacrococcygeal disorders, not elsewhere classified-Occipit-	0.000	0.998	0.001
M53.30 Sacrococcygeal disorders, not elsewhere classified-Mult sit	0.000	0.998	0.001
H90.2 Conductive hearing loss, unspecified	0.000	0.998	0.002
O36.5 Maternal care for poor foetal growth	0.000	0.998	0.002
Q82.5 Congenital nonneoplastic naevus	0.000	0.998	0.001
Y59.3 Immunoglobulin	0.001	0.998	0.000
B17 Other acute viral hepatitis	0.002	0.998	0.000
Y58 Bacterial vaccines	0.001	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.001	0.998	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.002	0.998	0.000
B17.9 Acute viral hepatitis, unspecified	0.001	0.998	0.000
C90.0 Multiple myeloma	0.001	0.998	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.998	0.001
Q82.2 Mastocytosis	0.000	0.998	0.001
R01.0 Benign and innocent cardiac murmurs	0.000	0.998	0.002
E27 Other disorders of adrenal gland	0.000	0.998	0.002
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.998	0.000
H61.8 Other specified disorders of external ear	0.000	0.998	0.002
S62.6 Fracture of other finger	0.000	0.998	0.002
Y47.1 Benzodiazepines	0.001	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.001	0.998	0.000
Y57.4 Pharmaceutical excipients	0.001	0.998	0.000
Y57.3 Alcohol deterrents	0.001	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.001	0.998	0.000
Y57.1 Lipotropic drugs	0.001	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.001	0.998	0.000
Q82 Other congenital malformations of skin	0.000	0.998	0.001
D80.8 Other immunodeficiencies with predominantly antibody defects	0.001	0.998	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.001	0.998	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.001	0.998	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.001	0.998	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.001	0.998	0.000
R43.8 Other and unspecified disturbances of smell and taste	0.001	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.001	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.998	0.000
I61 Intracerebral haemorrhage	0.000	0.998	0.001
M21.67 Other acquired deformities of ankle and foot-Ankle/foot	0.001	0.998	0.000
S06.00 Concussion (without open intracranial wound)	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations